| Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ... Aaps Pharmscitech 10 (1), 81-87, 2009 | 125 | 2009 |
| Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies YH Phillip Lee, S Sathigari, YJ Jean Lin, WR Ravis, G Chadha, ... Drug development and industrial pharmacy 35 (9), 1113-1120, 2009 | 59 | 2009 |
| In vitro percutaneous absorption of genistein from topical gels through human skin G Chadha, S Sathigari, DL Parsons, R Jayachandra Babu Drug development and industrial pharmacy 37 (5), 498-505, 2011 | 50 | 2011 |
| Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat. GS Chadha, ME Morris AAPS J 17 (4), 965-75, 2015 | 19 | 2015 |
| Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro CS Kolli, G Chadha, J Xiao, DL Parsons, RJ Babu Journal of drug targeting 18 (9), 657-664, 2010 | 16 | 2010 |
| Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression BL Morse, GS Chadha, MA Felmlee, KE Follman, ME Morris The American Journal of Drug and Alcohol Abuse, 1-8, 2017 | 11 | 2017 |
| An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in Rats GS Chadha, ME Morris The AAPS journal 17 (6), 1464-1474, 2015 | 11 | 2015 |
| Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy GS Chadha, ME Morris Current Pharmacology Reports 2 (2), 45-56, 2016 | 8 | 2016 |
| Transdermal Delivery of Genistein as a Chemoprotective Drug for Melanoma G Chadha | 3 | 2009 |
| IgG pharmacokinetics in a rat model of type 2 diabetes mellitus and diabetic nephropathy GS Chadha State University of New York at Buffalo, 2015 | | 2015 |